Search Tag: type 2 diabetes

2024 06 Sep

  Eli Lilly is making significant strides in developing efsitora alfa, a once-weekly insulin for treating type 2 diabetes. With positive preliminary results from two pivotal studies, Lilly is positioning itself as a strong competitor to Novo Nordisk, whose once-weekly insulin, icodec, is already available in multiple global markets. While Novo Nordisk’s...Read more